APA (7th ed.) Citation

Muralidhar, V., Alshalalfa, M., Spratt, D., Liu, S., Karnes, R., Schaeffer, E., . . . Nguyen, P. (2020). Clinical-Genomic Sub-classification of High-Risk Prostate Cancer: Implications for Tailoring Therapy and Clinical Trial Design. International Journal of Radiation Oncology, Biology, Physics, 108(3), e854. https://doi.org/10.1016/j.ijrobp.2020.07.414

Chicago Style (17th ed.) Citation

Muralidhar, V., et al. "Clinical-Genomic Sub-classification of High-Risk Prostate Cancer: Implications for Tailoring Therapy and Clinical Trial Design." International Journal of Radiation Oncology, Biology, Physics 108, no. 3 (2020): e854. https://doi.org/10.1016/j.ijrobp.2020.07.414.

MLA (9th ed.) Citation

Muralidhar, V., et al. "Clinical-Genomic Sub-classification of High-Risk Prostate Cancer: Implications for Tailoring Therapy and Clinical Trial Design." International Journal of Radiation Oncology, Biology, Physics, vol. 108, no. 3, 2020, p. e854, https://doi.org/10.1016/j.ijrobp.2020.07.414.